07Sep/22
Molecular Therapy: Development of New-Generation of Fully Human Single-Domain Antibody-Drug Conjugates Targeting Solid Tumors
An antibody-drug conjugate (ADC) is formed by linking monoclonal antibodies and small molecule cytotoxic drugs through linkers. It has both the tumor targeting of antibody drugs and the strong tumor-killing activity ofRead More…